PetVivo Holdings Inc Cash Flow Conversion Efficiency

Latest as of June 2025: -0.438x

PetVivo Holdings Inc cash flow conversion efficiency. Based on the latest financial reports, PetVivo Holdings Inc (PETV) has a cash flow conversion efficiency ratio of -0.438x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.63 Million) by net assets ($3.73 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of PetVivo Holdings Inc (2011–2025)

Cash flow conversion efficiency of PetVivo Holdings Inc from 2011 to 2025. This chart illustrates how PetVivo Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of PetVivo Holdings Inc for real-time trading data and today's change.

PetVivo Holdings Inc Cash Flow Conversion Ratio Explained

PetVivo Holdings Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

PetVivo Holdings Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PetVivo Holdings Inc ranked by their cash flow conversion efficiency. Also see market value of PetVivo Holdings Inc for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Hiroca Holdings Ltd
TW:1338
0.009x
Golden Lime PCL
BK:SUTHA
-0.110x
Opnet Technologies Co Ltd
TWO:8034
-0.003x
FIT INVEST JSC
VN:FIT
-0.020x
SGC eTEC E&C Co. Ltd
KQ:016250
-0.045x
Wisr Ltd
AU:WZR
0.105x
Advanced Braking Technology Ltd
AU:ABV
0.134x
Sunfar Computer Co Ltd
TWO:6154
-0.006x

Annual Cash Flow Conversion Efficiency for PetVivo Holdings Inc (2011–2025)

The table below shows the annual cash flow conversion efficiency of PetVivo Holdings Inc from 2011 to 2025. Review free cash flow generation of PetVivo Holdings Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 $4.22 Million $-5.32 Million -1.261x +88.34%
2024-03-31 $685.95K $-7.42 Million -10.816x -15.42%
2023-03-31 $725.02K $-6.79 Million -9.371x -1243.82%
2022-03-31 $5.99 Million $-4.17 Million -0.697x -159.73%
2021-03-31 $-896.98K $-1.05 Million 1.168x +143.63%
2020-03-31 $-1.04 Million $-496.59K 0.479x -45.02%
2019-03-31 $-844.82K $-736.45K 0.872x +120.57%
2018-03-31 $136.65K $-579.15K -4.238x -2329.30%
2017-03-31 $819.75K $-143.02K -0.174x -284.41%
2016-03-31 $15.21 Million $-690.33K -0.045x +98.16%
2015-03-31 $161.25K $-398.48K -2.471x -440.34%
2014-03-31 $-301.81K $-219.13K 0.726x +90.00%
2013-03-31 $-184.51K $-70.51K 0.382x +37.56%
2012-03-31 $-177.62K $-49.34K 0.278x -87.92%
2011-03-31 $-74.99K $-172.42K 2.299x --

About PetVivo Holdings Inc

NASDAQ:PETV USA Medical Devices
Market Cap
$35.24 Million
Market Cap Rank
#23006 Global
#5045 in USA
Share Price
$1.12
Change (1 day)
-16.09%
52-Week Range
$1.12 - $1.40
All Time High
$19.11
About

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for … Read more